no statement of use filed
on 17 Jul 2023
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
NJ
07054
Serial Number
88728509 filed on 16th Dec 2019
Registration Number
N/A
Correspondent Address
400 INTERPACE PARKWAY
PARSIPPANY NJ 07054
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and t Read More
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders
No 88728509
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Jul 2023 | ABANONMENT - NO USE STATEMENT ILE |
17th Jul 2023 | ABANONMENT NOTICE E-MAILE - NO USE STATEMENT ILE |
05th Jan 2023 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
04th Jan 2023 | CASE ASSIGNE TO INTENT TO USE PARALEGAL |
04th Jan 2023 | SOU EXTENSION 5 GRANTE |
14th Dec 2022 | SOU TEAS EXTENSION RECEIVE |
14th Dec 2022 | SOU EXTENSION 5 ILE |
17th Jun 2022 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
15th Jun 2022 | SOU TEAS EXTENSION RECEIVE |
15th Jun 2022 | SOU EXTENSION 4 ILE |